or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Representative Diana Louise DeGette's Public Statements on Drugs

Full Name: Diana Louise DeGette
Office: U.S. House (CO) - District 1, Democratic
First Elected: 11/05/1996
Last Elected: 11/06/2012
Next Election: 2014
Gender: Female
Family: Husband: Lino; 2 Children
Birth Date: 07/29/1957
Birth Place: Tachikawa, Japan
Home City: Denver, CO
Religion: Presbyterian
Date Title Location
March 8, 2013 DeGette And Coffman Re-Introduce Bipartisan Legislation To Respect States' Rights On Marijuana Washington, DC
June 20, 2012 Food and Drug Administration Safety and Innovation Act Washington, DC
May 31, 2012 DeGette, Rooney Drug Shortage Legislation Passes U.S. House Washington, DC
May 31, 2012 DeGette, Rooney Drug Shortage Legislation Passes U.S. House Washington, DC
May 10, 2012 DeGette, Rooney Legislation to Combat Drug Shortages Clears Committee Washington, DC
Feb. 21, 2012 DeGette Statement On FDA Drug Shortage Announcement Washington, DC
Feb. 17, 2012 Letter to The Honorable Margaret A. Hamburg, Commissioner U.S. Food and Drug Administration Unknown
Oct. 31, 2011 Rooney, DeGette Announce White House Support for Bill to Combat Drug Shortages Queens, NYC, NY
Oct. 31, 2011 Rooney, DeGette Announce White House Support for Bill to Combat Drug Shortages Washington, DC
Oct. 14, 2011 Letter to Co-Chairmen Murray and Hensarling of the Joint Select Committee on Deficit Reduction Washington, DC
Oct. 3, 2011 Letter to Chairman Upton and Chairman Stearns Washington, DC
Sept. 9, 2011 Letter to The Honorable Jon Leibowitz Chairman Federal Trade Commission Unknown
June 21, 2011 DeGette, Rooney Introduce Bill to Combat Drug Shortages Washington, DC
June 16, 2011 House Members Introduce Bipartisan Legislation to Combat Drug-Resistant Infections Washington, DC
June 16, 2011 Letter to The Honorable John Boehner, Speaker of the US House of Representatives Washington, DC
June 15, 2011 Rep. Eshoo and Bipartisan Coalition Introduce Bill to Combat the Rise of Drug-Resistant Infections Washington, DC
June 15, 2011 House Members Introduce Bipartisan Bill to Combat the Rise of Drug-Resistant Infections Unknown
April 13, 2011 Hearing of the Oversight and Investigations Subcommittee of the Energy and Commerce Committee - "Import Safety: Status of FDA's Screening Efforts at the Border" Unknown
April 12, 2011 Dingell, Waxman, Pallone, & DeGette Introduce Drug Safety Enhancement Act Washington, DC
March 24, 2011 Letter to Mr. Gregory J. Divis President Ther-Rx Corporation Chief Executive Officer KV Pharmaceutical Company Unknown
March 14, 2011 New GAO Report Highlights Importance of Health Care Reform Law's Medicare Drug Savings for Seniors Unknown
March 4, 2011 Letter to The Honorable Joseph R. Pitts Chairman Subcommittee on Health Unknown
June 25, 2009 Hearing Of The Health Subcommittee Of The House Committee On Energy And Commerce - Comprehensive Health Reform Discussion Draft, Day Three Washington, DC
June 11, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition Washington, DC
June 26, 2008 Legislation to Strengthen Smoking Prevention Efforts Washington, DC
June 26, 2008 Durbin, Degette & Platts Introduce Legislation to Strengthen Smoking Prevention Efforts Washington, DC
May 1, 2008 Increased Resources and FDA Authority Key to Pharmaceutical Safety Washington, DC
May 1, 2008 Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation Washington, DC
Nov. 1, 2007 Hearing of the Subcommittee on Oversight & Investigations of the House Committee on Energy and Commerce - FDA Foreign Drug Inspection Program Washington, DC
Sept. 26, 2007 Hearing of the House Subcommittee on Health of the House Committee on Energy and Commerce - H.R. 3610, The Food and Drug Import Saftey Act Washington, DC
Nov. 15, 2005 DeGette Launches New Web Page to Help Seniors Confused by Complicated Medicare Rx Drug Plan Washington, DC
Feb. 9, 2005 White House Admits Medicare Drug Plan Will Cost $720 BillionÂ…How Much Will Social Security Plan Really Cost Washington, DC
Back to top